The Global Airway Management Devices Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 7.2% CAGR during the forecast period.
Nasopharyngeal airways are inserted through one of the nostrils along the floor of the nasal passage. Lubrication may be applied to ease insertion. Therefore, the nasopharyngeal devices segment captured $203.2 million revenue in the market in 2022. The device is advanced gently until it reaches the nasopharynx. Unlike oropharyngeal airways, nasopharyngeal airways can be used in patients with intact gag reflexes. Nasopharyngeal airways are commonly employed in emergency medical settings, including pre-hospital care and ambulance services.
Targeted screening programs identify high-risk populations, such as individuals with a history of smoking, occupational exposure, or a family history of respiratory diseases. Identifying individuals at risk for respiratory disorders contributes to the proactive use of airway devices. As awareness grows and individuals participate in early detection efforts, the market for these devices is likely to increase.
Additionally, the prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and sleep apnea, is on the rise globally. As per a report by World Health Organization (WHO) updated in 2023, With 3.23 million fatalities from chronic obstructive pulmonary disease (COPD) in 2019, it ranks as the third most common cause of mortality globally.
However, Pediatric patients require these devices specifically designed to accommodate their smaller anatomy. Pediatric-specific research and clinical trials for the devices are often scarce. The lack of robust evidence-based practices for pediatric airway management may result in varied approaches, creating standardization and device selection challenges. As a result, the above aspects will cause the market growth to decline.
Furthermore, the surge in COVID-19 cases, particularly severe cases leading to acute respiratory distress syndrome (ARDS), increased demand for ventilators and other respiratory support devices. These devices, including endotracheal and tracheostomy tubes, are integral to mechanical ventilation systems used in critical care settings. The urgency of the pandemic prompted accelerated research and innovation in the field of respiratory care, including airway management. There was a focus on developing new technologies, improving existing devices, and exploring alternative methods of airway management to enhance patient outcomes and reduce the burden on healthcare systems. Therefore, COVID-19 had a positive impact on the market.
Drivers 
Restraints 
Opportunities 
Challenges Based on application, the market is fragmented into anesthesia, emergency medicine, and others. In 2022, the anesthesia segment witnessed 58.14% revenue share in the market. Endotracheal intubation is a common technique in anesthesia. It allows the anesthesiologist to control the airway, administer inhalation anesthetics, and ensure adequate oxygenation and ventilation during surgery.
By end-use, the market is categorised into hospitals, homecare, and others. The homecare segment acquired a 28.06% revenue share in the market in 2022. Due to the increasing launches of instruments and equipment for managing airways in home settings.
On the basis of product, the market is segmented into supraglottic devices, infraglottic devices, resuscitators, laryngoscopes, and others. In 2022, the supraglottic devices segment dominated the market with the 36.14% revenue share. The growing demand for these products can be attributed to their associated benefits. The most important advantage includes easy tracheal placement, which leads to improved patient safety.
Under supraglottic devices type, the market is further divided into oropharyngeal devices, nasopharyngeal devices, laryngeal airway masks, and others. In 2022, the oropharyngeal devices segment held 46.20% revenue share in the market. Oropharyngeal airways are commonly used when the patient is unconscious, under general anesthesia, or unable to maintain a clear airway independently.
Under infraglottic devices type, the market is further classified into endotracheal tubes, tracheostomy tubes, and others. In 2022, the endotracheal tubes segment registered 46.57% revenue share in the market. Endotracheal intubation can be performed through the oral or nasal route. The choice depends on factors such as the patient's condition, the surgical procedure, and the healthcare provider's preferences.
Free Valuable Insights: Global Airway Management Devices Market size to reach USD 3.5 Billion by 2030
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a 26.15% revenue share in the market in 2022. Due to the increase in the outsourcing of the manufacturing of these devices to Asia Pacific countries, such as India and China.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 2 Billion |
| Market size forecast in 2030 | USD 3.5 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 7.2% from 2023 to 2030 |
| Number of Pages | 322 |
| Number of Tables | 560 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, Application, End-use, Region |
| Country scope |
|
| Companies Included | Medtronic PLC, Teleflex Incorporated, Ambu A/S, Becton, Dickinson, and Company, Medline Industries, Inc., ICU Medical, Inc. (Smiths Medical), ConvaTec Group PLC, Armstrong Medical Ltd, Intersurgical Ltd, Mercury Medical |
By Application
By End-use
By Product
By Geography
The Market size is projected to reach USD 3.5 billion by 2030.
Expansion of technological innovations are driving the Market in coming years, however, High costs of advanced technologies restraints the growth of the Market.
Medtronic PLC, Teleflex Incorporated, Ambu A/S, Becton, Dickinson, and Company, Medline Industries, Inc., ICU Medical, Inc. (Smiths Medical), ConvaTec Group PLC, Armstrong Medical Ltd, Intersurgical Ltd, Mercury Medical
The expected CAGR of this Market is 7.2% from 2023 to 2030.
The Hospitals segment is leading the Market by End-use in 2022; there by, achieving a market value of $2 billion by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; there by, achieving a market value of $1.3 billion by 2030.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
